Non-Alcoholic Steatohepatitis Pathogenesis: Role of Repair in Regulating the Disease Progression

被引:24
作者
Jung, Youngmi [1 ]
Diehl, Anna Mae [1 ]
机构
[1] Duke Univ, Div Gastroenterol, Durham, NC 27710 USA
关键词
Apoptosis; Liver regeneration; Fibrogenesis; Progenitors; Hedgehog; FATTY LIVER-DISEASE; IKK-BETA; HEDGEHOG; ACTIVATION; APOPTOSIS; VIABILITY; CELLS;
D O I
10.1159/000282092
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Increased hepatocyte apoptosis distinguishes non-alcoholic steatohepatitis (NASH) from non-alcoholic fatty liver disease (NAFLD). Therefore, we postulated that outcomes of NASH depended upon whether or not hepatic regenerative responses could keep pace with the increased rate of hepatocyte death. Methods: To investigate mechanisms that the liver deploys to compensate for increased hepatocyte apoptosis, we studied a transgenic mouse model in which hepatocyte vulnerability to apoptosis was increased due to disruption of NF-kappa B survival signaling. Results: We learned that hepatocyte death is coupled to the expansion of cell types that are involved in liver repair, including progenitors and myofibroblasts, and discovered that the outgrowth of these cell types occurs, at least in part, because dying hepatocytes produce Hedgehog morphogens that enhance the growth of progenitor and myofibroblast populations. The clinical significance of this discovery is supported by evidence that the degree of Hedgehog pathway activation also parallels the severity of liver fibrosis in patients with NASH, a disease in which hepatocyte apoptotic activity has been strongly linked to fibrosis progression. Conclusion: The data generated by studying a mouse model of chronic hepatocyte apoptosis, as well as NASH, a common human liver disease that is characterized by increased rates of hepatocyte apoptosis, are very similar. Both strongly support the concept that repair responses play an important role in controlling the outcomes of NASH. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:225 / 228
页数:4
相关论文
共 50 条
  • [31] MRG15 aggravates non-alcoholic steatohepatitis progression by regulating the mitochondrial proteolytic degradation of TUFM
    Tian, Cheng
    Min, Xuewen
    Zhao, Yongxu
    Wang, Yuchen
    Wu, Xiaoshan
    Liu, Situn
    Dou, Wei
    Zhou, Tingting
    Liu, Yan
    Luo, Rongkui
    Li, Zhigang
    Lui, Kathy O.
    Li, Yu
    Zhou, Ben
    Ding, Qiurong
    JOURNAL OF HEPATOLOGY, 2022, 77 (06) : 1491 - 1503
  • [32] Role of vitamin E in the treatment of non-alcoholic steatohepatitis
    Sumida, Yoshio
    Yoneda, Masato
    Seko, Yuya
    Takahashi, Hirokazu
    Hara, Nagisa
    Fujii, Hideki
    Itoh, Yoshito
    Yoneda, Masashi
    Nakajima, Atsushi
    Okanoue, Takeshi
    FREE RADICAL BIOLOGY AND MEDICINE, 2021, 177 : 391 - 403
  • [33] Clinical Management of Non-alcoholic Steatohepatitis and the Role of the Cardiologist
    Millan-Rodriguez, Carlos
    Castello, Carlos Palacios
    Caballero-Valderrama, Maria de Regla
    Esquivias, Gonzalo Baron
    EUROPEAN CARDIOLOGY REVIEW, 2023, 18
  • [34] The Role of Metabolic Surgery in Non-alcoholic Steatohepatitis Improvement
    Caravatto, Pedro Paulo
    Cohen, Ricardo
    CURRENT ATHEROSCLEROSIS REPORTS, 2017, 19 (11)
  • [35] Non-alcoholic steatohepatitis: a microbiota-driven disease
    Moschen, Alexander R.
    Kaser, Susanne
    Tilg, Herbert
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2013, 24 (11) : 537 - 545
  • [36] Identification of Autophagy-Related Genes in the Progression from Non-Alcoholic Fatty Liver to Non-Alcoholic Steatohepatitis
    Ma, Mengyao
    Xie, Wenhua
    Li, Xi
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 3163 - 3176
  • [37] Fructose and Non-Alcoholic Steatohepatitis
    Roeb, Elke
    Weiskirchen, Ralf
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [38] Statins in Non-alcoholic Steatohepatitis
    Torres-Pena, Jose D.
    Martin-Piedra, Laura
    Fuentes-Jimenez, Francisco
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [39] Non-alcoholic Steatohepatitis: An Overview
    Shifflet, Allison
    Wu, George Y.
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2009, 108 (01) : 4 - 12
  • [40] Pathogenesis of non-alcoholic fatty liver disease
    Anty, Rodolphe
    Gual, Philippe
    PRESSE MEDICALE, 2019, 48 (12): : 1468 - 1483